|
Volumn 97, Issue 1, 2003, Pages 12-13
|
Proposing the motion
|
Author keywords
Chemotherapy; Drugs; Essential drugs list
|
Indexed keywords
ALBENDAZOLE;
AMODIAQUINE;
ANTHELMINTIC AGENT;
ANTIBIOTIC AGENT;
ANTIMALARIAL AGENT;
ANTINEOPLASTIC AGENT;
ANTIVIRUS AGENT;
ARTEMETHER;
ARTESUNATE;
BENZIMIDAZOLE DERIVATIVE;
BEPHENIUM;
CHLOROQUINE;
GENERIC DRUG;
LEVAMISOLE;
MEBENDAZOLE;
MEFLOQUINE;
NICLOSAMIDE;
PIPERAZINE;
PRAZIQUANTEL;
PRIMAQUINE;
PROGUANIL;
PYRANTEL;
PYRIMETHAMINE;
QUININE;
SULFADOXINE;
TETRACYCLINE;
TIABENDAZOLE;
ANTIBIOTIC RESISTANCE;
ARTICLE;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DEVELOPING COUNTRY;
DRUG BIOAVAILABILITY;
DRUG COST;
DRUG FORMULARY;
DRUG FORMULATION;
DRUG QUALITY;
DRUG USE;
HEALTH CARE SYSTEM;
HELMINTHIASIS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALARIA FALCIPARUM;
MALIGNANT NEOPLASTIC DISEASE;
WORLD HEALTH ORGANIZATION;
ARTESUNATE;
CINCHONA PUBESCENS;
HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 0038637227
PISSN: 00359203
EISSN: None
Source Type: Journal
DOI: 10.1016/S0035-9203(03)90004-6 Document Type: Conference Paper |
Times cited : (3)
|
References (1)
|